All In MedTech

FDA Clearance Tracker · P040043-S037

GORE TAG THORACIC ENDOPROSTESIS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 24, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 24, 2011

Approved

Time to decision

175 days

Received Sep 2, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P040043-S037
Device name
GORE TAG THORACIC ENDOPROSTESIS
Applicant location
Flagstaff, AZ
Received
Sep 2, 2010
Decided
Feb 24, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P040043

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

APPROVAL TO UPDATE THE GORE TAG THORACIC ENDOPROSTHESIS INSTRUCTIONS FOR USE TO INCLUDE SUMMARY INFORMATION ON THE EVALUATION OF THE PHYSICIAN TRAINING PROGRAM FOR THIS DEVICE.

Source documents

Other decisions for W. L. Gore & Associates, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.